Microbiology-Immunology-Tropical Medicine

The George Washington University Vaccine Research Unit in partnership with Scripps Research, IAVI, Fred Hutchinson Cancer Center (FHCC) and the National Institutes of Health, National Institute of Allergy and Infectious Diseases Vaccine Research Center published the results of their Phase 1…
Though antiretroviral therapy has made HIV a manageable disease, people living with HIV often suffer from chronic inflammation. This can put them at an increased risk of developing comorbidities such as cardiovascular disease and neurocognitive dysfunction, impacting the longevity and quality of…
Two D.C.-area facilities are recruiting volunteers to test the efficacy of different doses of a monkeypox vaccine with the hope that they can stretch available supplies. The National Institutes of Health, in Bethesda, Maryland, and George Washington University, in D.C., are among eight locations…
The GW School of Medicine and Health Sciences has been selected to serve as one of 24 participating sites for the Phase 2 clinical trial to evaluate additional COVID-19 booster shots in adults, including multiple vaccines based on viral variants such as Delta and Omicron. The trial aims to…
A $1 million gift from Ulvi M. and Reykhan Kasimov seeks to advance development of a new technique that uses RNA transcript levels to identify biomarkers in the blood stream, which can help detect active infections in the body.
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) was recently awarded a National Institutes of Health (NIH) T-32 research training grant. The five-year grant, worth nearly $1 million overall, will support the training of junior scientists who will advance research…
The George Washington University School of Medicine and Health Sciences researchers have been awarded a $3.6 million contract to genetically modify commensal organisms to produce antidotes for harmful biological and chemical agents, such as anthrax, Ebola, and even COVID-19.
David Diemert, MD, clinical director of the GW Vaccine Research Unit and professor of medicine at the George Washington University School of Medicine and Health Sciences discusses what scientists know about the Delta variant.
Michael Bukrinsky, MD, PhD, professor of microbiology, immunology, and tropical medicine at the George Washington University School of Medicine and Health Sciences, is conducting two studies focusing on HIV-associated disorders, with the support of grants from the National Institutes of Health. 
Katherine Chiappinelli, PhD, assistant professor of microbiology, immunology, and tropical medicine at the George Washington University School of Medicine and Health Sciences, received a $1.87 million grant from the National Institutes of Health to research the regulation of repetitive elements in…